ARK Investment Management’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
CS
B
ARK Investment Management's CLLS Position: Q1 2022 in Review
ARK Investment Management sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 2,941,556 shares — an estimated $23.9M sold.
ARK Investment Management first reported a position in CLLS in Q1 2017 and held it in 20 quarters. The position peaked at $181M in Q4 2020. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.
- ARK Investment Management reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
- ARK Investment Management sold 2,941,556 Cellectis shares in Q1 2022, an estimated $23.9M.
- ARK Investment Management first reported a position in Cellectis in Q1 2017 and held it in 20 quarters.
- ARK Investment Management's Cellectis position peaked at $181M in Q4 2020.
- 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.
Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.